Clinical trial
Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in…
NCT00399074 · Makerere University, Other · Completed
Key facts
| NCT number | NCT00399074 |
|---|---|
| Title | Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia |
| Official title | Presumptive Treatment With Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prophylaxis in Children With Sickle Cell Anemia |
| Lead sponsor | Makerere University, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sickle Cell Anemia, Malaria |
| Intervention type | Drug |
| Interventions | sulfadoxine pyrimethamine |
| Enrollment | 220 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Nov 14, 2006 |
| Last update posted | Jul 2, 2009 |
| Countries | Uganda |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: